Aseptic services provide a sterile, controlled environment for preparing specific injectable medicines including chemotherapy, injectable nutrition for patients, and clinical trials.
To deliver safer, more efficient and resilient aseptic services, improve patient care, and meet the growth in demand for chemotherapy and clinical trials outlined in the NHS Long Term Plan, we are seeking views and evidence-based examples of existing challenges and opportunities, innovative practice, and potentially transformative change in aseptic services.
Proposals and evidence of where regulatory, legislative or organisational change is required to improve both the safety and resilience of these services are welcome, together with indications of how any proposed reforms might work.
We welcome submissions from individuals, NHS and commercial organisations, networks at local, regional, national and international levels. Individuals and organisations will be invited to give verbal evidence in November 2019.
This review is a result of Lord Carter’s report into Operational productivity and performance in English NHS acute hospitals: unwarranted variations 2016, which looked at the efficiency and cost effectiveness of aseptic services in England — leading on to further work around capacity and resilience in the sector.